Cancer cells are often able to evade the immune system through several mechanisms. They can produce signals that inhibit immune responses, downregulate antigens that T cells recognize, or create an immunosuppressive microenvironment. Additionally, some cancer cells express immune checkpoint proteins, like PD-L1, which bind to PD-1 receptors on T cells, effectively "turning off" the T cells.
